Literature DB >> 11371718

The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.

W Hundt1, U Zimmermann, M Pöttig, K Spring , F Holsboer.   

Abstract

BACKGROUND: Chronic alcoholism is often accompanied by disturbances of the hypothalamic-pituitary-adrenal (HPA) system. Patients with alcoholism frequently show nonsuppression in the dexamethasone (Dex) suppression test and also a blunted increase of adrenocorticotropin (ACTH) after injection of corticotropin-releasing hormone (hCRH). However, the underlying mechanisms have not been fully elucidated. The combined Dex/CRH test (pretreatment with 1.5 mg dexamethasone at 2300 hr, injection of 100 microg hCRH at 1500 hr the next day) has been established as a more sensitive tool to investigate HPA system regulation in depressed patients.
METHODS: We studied the effect of the combined Dex/CRH test in 19 alcoholic inpatients (9 male, 10 female) during and after withdrawal along with 19 healthy controls.
RESULTS: Compared to normal controls, patients showed a severely dysregulated HPA system during withdrawal, with significantly elevated cortisol and ACTH response to hCRH after pretreatment with dexamethasone. After completed withdrawal, cortisol levels after injection of hCRH were almost normalized while ACTH values were partially lower in patients, compared to controls.
CONCLUSIONS: We conclude that the HPA system is severely disturbed during alcohol withdrawal, possibly reflecting an exaggerated release of hypothalamic corticotropin and vasopressin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371718

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  16 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Functional CRH variation increases stress-induced alcohol consumption in primates.

Authors:  Christina S Barr; Rachel L Dvoskin; Manisha Gupte; Wolfgang Sommer; Hui Sun; Melanie L Schwandt; Stephen G Lindell; John W Kasckow; Stephen J Suomi; David Goldman; J Dee Higley; Markus Heilig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

3.  Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder.

Authors:  Boadie W Dunlop; Yara Betancourt; Elisabeth B Binder; Christine Heim; Florian Holsboer; Marcus Ising; Melissa McKenzie; Tanja Mletzko; Hildegard Pfister; Charles B Nemeroff; W Edward Craighead; Helen S Mayberg
Journal:  J Psychiatr Res       Date:  2010-05-20       Impact factor: 4.791

Review 4.  [The NMDA receptor system: genetic risk factor for alcoholism].

Authors:  G Schumann; C Saam; A Heinz; K Mann; J Treutlein
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

Review 5.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

6.  Corticotropin-releasing factor overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol.

Authors:  Abraham A Palmer; Amanda L Sharpe; Sue Burkhart-Kasch; Carrie S McKinnon; Sarah C Coste; Mary P Stenzel-Poore; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2004-05-11       Impact factor: 4.530

7.  Sex differences in the ACTH and cortisol response to pharmacological probes are stressor-specific and occur regardless of alcohol dependence history.

Authors:  Robert M Anthenelli; Jaimee L Heffner; Thomas J Blom; Belinda E Daniel; Benjamin S McKenna; Gary S Wand
Journal:  Psychoneuroendocrinology       Date:  2018-05-04       Impact factor: 4.905

8.  Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy.

Authors:  Astrid Zobel; Jörg Wellmer; Svenja Schulze-Rauschenbach; Ute Pfeiffer; Susanne Schnell; Christian Elger; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

Review 9.  Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior.

Authors:  A Leslie Morrow; Patrizia Porcu; Kevin N Boyd; Kathleen A Grant
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

10.  Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumption.

Authors:  Terence Y Pang; Xin Du; William A Catchlove; Thibault Renoir; Andrew J Lawrence; Anthony J Hannan
Journal:  Front Pharmacol       Date:  2013-07-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.